Related Experiment Video
Updated: Jul 12, 2026
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma.
Emmanuel Akinyemi1, Le Mai, Abu Matin
1Internal Medicine, Coney Island Hospital, Brooklyn, NY, USA. yemmy68@yahoo.com
Journal of the National Medical Association
|August 29, 2007
Summary
Primary cutaneous B-cell lymphomas (PCBCLs) are skin-confined cancers with a high survival rate. This case highlights a rare presentation of diffuse large B-cell lymphoma (DLBCL) mimicking skin cancer.
Area of Science:
- Dermatology
- Oncology
- Hematology
Background:
- Primary cutaneous B-cell lymphomas (PCBCLs) are a diverse group of skin-limited B-cell lymphoproliferative disorders.
- PCBCLs generally have an excellent prognosis, with a five-year survival rate of approximately 95% when diagnosed and treated early.
Observation:
- A case of diffuse large B-cell lymphoma (DLBCL) is presented in a 52-year-old woman.
- The DLBCL manifested as a fungating skin ulcer, closely resembling advanced basal cell carcinoma.
Findings:
- Literature review indicates a predominance of PCBCL studies in European populations.
- A universally accepted classification system for PCBCLs is lacking.
- The study discusses clinical findings, diagnostic evaluations, and treatment outcomes for PCBCLs.
Implications:
- Comparison between the European Organization for Research and Treatment of Cancer (EORTC) and World Health Organization (WHO) classification systems for PCBCLs is emphasized.
- Accurate classification and diagnosis are crucial for effective management of PCBCLs.
- Understanding rare presentations of DLBCL is important for differential diagnosis in dermatology.
